Stocktwits on MSN
Theriva™ Biologics licenses SYN-020 to Rasayana Therapeutics for multiple indications
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...
2hon MSN
Turn an average sentence into a standout phrase with two-year access to MasterWriter for $100
TL;DR: Give yourself a writing upgrade with this two-year license to the Creative Writer version of MasterWriter, now for ...
Preclinical data demonstrate >90% reduction in human cytomegalovirus (HCMV) reactivation from latency, establishing proof-of-concept for ...
Blackbaud is seeing faster-than-expected adoption of artificial intelligence across the nonprofit sector, with President and ...
Digi International (NASDAQ:DGII) shares rose 3.2% Wednesday following the company’s announcement of a new Model Context Protocol server for its Digi Remote Manager and Genesis platforms. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results